Banyan Corp. (BNYN)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
At close: Jul 15, 2025
Banyan Revenue
Banyan had revenue of $696.36K in the quarter ending June 30, 2008, a decrease of -48.71%. This brings the company's revenue in the last twelve months to $3.48M, down -37.69% year-over-year. In the year 2007, Banyan had annual revenue of $5.00M, down -8.21%.
Revenue (ttm)
3.48M
Revenue Growth
-37.69%
P/S Ratio
0.08
Revenue / Employee
174.03K
Employees
20
Market Cap
290.56K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2007 | 5.00M | -447.31K | -8.21% |
| Dec 31, 2006 | 5.45M | 4.36M | 399.73% |
| Dec 31, 2005 | 1.09M | 625.06K | 134.21% |
| Dec 31, 2004 | 465.73K | 411.59K | 760.26% |
| Dec 31, 2003 | 54.14K | -743.99K | -93.22% |
| Dec 31, 2002 | Pro | Pro | Pro |
| Dec 31, 2001 | Pro | Pro | Pro |
| Dec 31, 2000 | Pro | Pro | Pro |
| Dec 31, 1999 | Pro | Pro | Pro |
| Dec 31, 1998 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo, Inc. | 1.73B |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 84.04M |
| Glass House Brands | 215.62M |
| Northwest Biotherapeutics | 1.47M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 27.70M |